Zimbabwe has rejected a significant American healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' demand for confidential data.
The decision became public after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesman later explained that the United States was demanding access to biological samples for research and commercial gain while was not willing to share the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Implications
Zimbabwe's decision follows a similar case in Kenya, where a court suspended a similar deal with the US following concerns were filed about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had managed aid for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.
According to reports, Sixteen African countries have so far signed these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Effectively, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be available to our people should a future health crisis emerge."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already established via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This system is designed to ensure that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our US partners on how subsequent collaboration might be structured in a manner that respects the independence and interests of each country."
Health Experts Reaction
A leading public health body stated it understood the government's concerns, but suggested that negotiations should continue given that much of the nation's Aids initiatives depended on international support.
"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it said.
This impasse underscores the ongoing challenges between accepting much-needed international aid and protecting a country's data in an ever more interconnected world.